Development of a Novel Class of Interleukin-2 Immunotherapies for Metastatic Cancer

Swiss Medical Weekly - Switzerland
doi 10.4414/smw.2019.14697
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

EMH Swiss Medical Publishers, Ltd.

Related search

Novel Cancer Immunotherapies and Antitumor Immunity

Journal of Immunology Research
MedicineAllergyImmunology
2019English

Advances in the Development of Cancer Immunotherapies

Trends in Immunology
AllergyImmunology
2013English

Novel Immunotherapies for Autoimmune Hepatitis

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2017English

Proteomic Identification of Interleukin-2 Therapy Response in Metastatic Renal Cell Cancer

Journal of Urology
Urology
2008English

Viral Boost for Cancer Immunotherapies

Science-Business eXchange
2011English

Past, Current, and Future of Immunotherapies for Prostate Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Novel Immunotherapies in Lymphoid Malignancies

Nature Reviews Clinical Oncology
Oncology
2015English

Development of a Brain Metastatic Canine Prostate Cancer Cell Line

Prostate
OncologyUrology
2011English

2-Triazenoazaindoles: A Novel Class of Triazenes Inducing Transcriptional Down-Regulation of EGFR and HER-2 in Human Pancreatic Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy